The ValenTx Endo Bypass System in Obese Subjects

NCT02954003 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2016-11-03

No results posted yet for this study

Summary

The purpose of this study is to collect clinical data to support the use of the ValenTx Endo Bypass System to improve weight loss and the resolution of comorbidities in obese subjects.

Conditions

Interventions

DEVICE

Endo Bypass System

Subject is implanted with the device for up to 3 years.

Sponsors & Collaborators

  • ValenTx, Inc.

    lead INDUSTRY

Principal Investigators

  • Roland Maude-Griffin · ValenTx, Inc.

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2015-10-31
Completion
2018-10-31

Countries

  • Canada
  • Mexico

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02954003 on ClinicalTrials.gov